| 2023年年报 | 2023年中报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 农药(元) | 3,508,856,605.83 | - | 5,658,556,112.00 |
| 农药中间体及其他(元) | 2,309,115,718.73 | - | 3,382,685,220.29 |
| 东至广信(元) | - | 2,192,605,686.38 | - |
| 分部间抵销(元) | - | -1,430,389,245.31 | - |
| 广信股份(元) | - | 2,611,226,297.74 | - |
| 广信通达(元) | - | 21,864,281.12 | - |
| 广信亚洲(元) | - | 5,617,605.29 | - |
| 世星药化(元) | - | 371,066,518.29 | - |
| 营业成本(元) | |||
| 农药(元) | 2,163,315,968.93 | - | 3,264,920,171.29 |
| 农药中间体及其他(元) | 1,475,056,592.18 | - | 2,079,232,557.51 |
| 东至广信(元) | - | 1,603,566,514.52 | - |
| 分部间抵销(元) | - | -1,379,111,667.99 | - |
| 广信股份(元) | - | 1,863,765,593.12 | - |
| 广信通达(元) | - | 18,458,701.19 | - |
| 广信亚洲(元) | - | 4,677,943.40 | - |
| 世星药化(元) | - | 246,751,363.50 | - |
| 毛利(元) | |||
| 农药(元) | 1,345,540,636.90 | - | 2,393,635,940.71 |
| 农药中间体及其他(元) | 834,059,126.55 | - | 1,303,452,662.78 |
| 东至广信(元) | - | 589,039,171.86 | - |
| 分部间抵销(元) | - | -51,277,577.32 | - |
| 广信股份(元) | - | 747,460,704.62 | - |
| 广信通达(元) | - | 3,405,579.93 | - |
| 广信亚洲(元) | - | 939,661.89 | - |
| 世星药化(元) | - | 124,315,154.79 | - |
| 毛利率(%) | |||
| 农药(%) | 38.35 | - | 42.30 |
| 农药中间体及其他(%) | 36.12 | - | 38.53 |
| 东至广信(%) | - | 26.86 | - |
| 分部间抵销(%) | - | 3.58 | - |
| 广信股份(%) | - | 28.62 | - |
| 广信通达(%) | - | 15.58 | - |
| 广信亚洲(%) | - | 16.73 | - |
| 世星药化(%) | - | 33.50 | - |
| 收入构成(%) | |||
| 农药(%) | 60.31 | - | 62.59 |
| 农药中间体及其他(%) | 39.69 | - | 37.41 |
| 东至广信(%) | - | 58.13 | - |
| 分部间抵销(%) | - | -37.92 | - |
| 广信股份(%) | - | 69.23 | - |
| 广信通达(%) | - | 0.58 | - |
| 广信亚洲(%) | - | 0.15 | - |
| 世星药化(%) | - | 9.84 | - |
| 毛利构成(%) | |||
| 农药(%) | 61.73 | - | 64.74 |
| 农药中间体及其他(%) | 38.27 | - | 35.26 |
| 东至广信(%) | - | 41.66 | - |
| 分部间抵销(%) | - | -3.63 | - |
| 广信股份(%) | - | 52.87 | - |
| 广信通达(%) | - | 0.24 | - |
| 广信亚洲(%) | - | 0.07 | - |
| 世星药化(%) | - | 8.79 | - |